T20SN26LY-1-02 — SPB Tirzepatide
Independently TestedSPB | Tirzepatide, last activity 2 months ago
Janoshik tested this batch at 99.56% purity with 21.62 mg measured; a community group test for this peptide is currently shipped to the same lab. SPB rarely publishes its own certificates, making independent testing unusual for this vendor. Three positive reports are on record. The batch was first seen one to three months ago.
8 related batch concerns · 3 mentions · summary from 9 sources · updated Sep 1
Get notified when a lab result is posted, a group test forms, or this batch is flagged by the community.
Test Results
The label says 20 mg. Janoshik weighed 21.6 mg — 8% more than the label. Your dose depends on what is really in the vial, so the steps below use the measured amount.
Draw
19 units
on a U-100 insulin syringe, for 2 mg
Going by the label you would draw 20 units — which from this vial is actually 2.16 mg, not 2 mg.
- The vial holds dry powder: 21.6 mg of Tirzepatide, as weighed.
- Water spreads that powder evenly through the liquid: 21.6 mg ÷ 2 ml = 10.8 mg per ml.
- An insulin syringe counts in units, 100 to the ml, so each unit carries 108 mcg.
- Your dose divided by that: 2 mg ÷ 108 mcg = 19 units.
The water changes how many units a dose takes, never how much peptide you get. Twice the water means twice the units for the same dose. What sets the dose is how much is in the vial — which is why the measured amount matters.
Arithmetic, not medical advice. Assumes a U-100 syringe and that the powder fully dissolves. The figure is from the vial that was tested; yours is from the same lot but was not weighed itself.
Related batches
3 of 5 tested
also SPB
SPB rarely publishes certificates, and this batch has two quality concerns reported against it
KLOW, same vendor
An independent test found endotoxin at 49 EU/vial, over the 10 EU/vial working limit
GYC/GGpeps
Endotoxin levels have exceeded the 10 EU/vial working limit in two independent Janoshik tests (17.116 and 47.923…
also SPB
Three community reports describe problems with this batch, and a group test has shipped to Vanguard Laboratory for…
also SPB
One community report describes a problem with this batch
Group Tests
Organized by SPB
Lab: Janoshik
Updated 2 months ago
Community Intelligence
- 2 concern reports involving SN26XY-1-02
- 3 concern reports involving T10SN26LY-1-01
- 1 concern report involving T30SN26XY-1-02
- 2 concern reports involving KL8026LY-1C
- 3 concern reports involving EPI10SJ26-1-01
- 2 concern reports involving SJ26LY-1-01
- 1 concern report involving SJ26-4-01
- 1 concern report involving 2026061030
Reported against other SPB Tirzepatide batches, not this one.
Also known as: SN26LY102T2026LY3PT20S26LY102SN26LY-1-02T203PSN26LY-1-02 (July-2026)T20S26LY-1-02T20-3PT2026LY-3P
Activity
The results are here: https://verify.janoshik.com/tests/209929-T20_S_95NRAEILMQ5G TIRZEPATIDE T20 S SN26LY-1-02
View in Telegram →members only[](https://glp1forum.com/attachments/1785458137360-webp.33626/)T20-3P: [https://verify.janoshik.com/tests/209929-T20_S_95NRAEILMQ5G](https://verify.janoshik.com/tests/209929-T20_S_95NRAEILMQ5G)
T20-3P: https://verify.janoshik.com/tests/209929-T20_S_95NRAEILMQ5G
View in Telegram →members onlyVendor
SPB